EFFECT OF REPEATED TREATMENT WITH DESIPRAMINE IN THE BEHAVIORAL DESPAIR TEST IN RATS - ANTAGONISM BY ATYPICAL BUT NOT CLASSICAL NEUROLEPTICS OR ANTIADRENERGIC DRUGS
EFFECT OF REPEATED TREATMENT WITH DESIPRAMINE IN THE BEHAVIORAL DESPAIR TEST IN RATS - ANTAGONISM BY ATYPICAL BUT NOT CLASSICAL NEUROLEPTICS OR ANTIADRENERGIC DRUGS
复制标题
DOI:
10.1016/0024-3205(84)90089-4
复制
发表时间:
1984-01-01
期刊:
影响因子:
6.1
通讯作者:
SAMANIN, R
中科院分区:
文献类型:
--
作者:
BORSINI, F;NOWAKOWSKA, E;SAMANIN, R
A 7-day treatment with 20 mg/kg per day desipramine [DMI] reduced the immobility time in the behavioral despair test in rats. The effect of DMI was antagonized by sulpiride (100 mg/kg i.p.), metoclopramide (20 mg/kg i.p.) and clopazine (20 mg/kg i.p.) but not by haloperidol (0.5 mg/kg i.p.) or chlorpromazine (5 mg/kg i.p.). .alpha.-Adrenoreceptor blockers (prazosin 3 mg/kg s.c.; aceperone 10 mg/kg i.p.; azapetine 24 mg/kg s.c.; phentolamine 20 mg/kg i.p.), dl-propranolol (5 mg/kg i.p.) and clonidine (0.1 mg/kg i.p.) failed to modify the anti-immobility effect of DMI. Apparently, a particular subtype of dopamine receptors is involved in the anti-immobility effect of a 7-day treatment with DMI in the behavioral despair test in rats.